Senseonics (NYSE:SENS) Earns Buy Rating from Analysts at TD Cowen

Analysts at TD Cowen started coverage on shares of Senseonics (NYSE:SENS - Get Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The brokerage set a "buy" rating and a $1.25 price target on the stock. TD Cowen's price target would indicate a potential upside of 143.14% from the stock's previous close.

Several other analysts have also commented on SENS. Mizuho started coverage on Senseonics in a research note on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price target on the stock. Wall Street Zen raised Senseonics to a "sell" rating in a research note on Monday, May 12th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $1.40 price target (up previously from $1.10) on shares of Senseonics in a research note on Tuesday, July 8th.

Senseonics Stock Up 4.3%

Shares of NYSE SENS traded up $0.02 during mid-day trading on Tuesday, reaching $0.51. 14,889,625 shares of the company traded hands, compared to its average volume of 7,221,688. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The stock has a market cap of $336.33 million, a PE ratio of -3.95 and a beta of 0.92. The company's fifty day moving average is $0.53 and its two-hundred day moving average is $0.68. Senseonics has a fifty-two week low of $0.25 and a fifty-two week high of $1.40.

Institutional Trading of Senseonics

Hedge funds have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. lifted its holdings in Senseonics by 9.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock worth $1,748,000 after purchasing an additional 274,842 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Senseonics during the 4th quarter worth approximately $26,000. HighTower Advisors LLC acquired a new stake in Senseonics during the 4th quarter worth approximately $32,000. Virtu Financial LLC acquired a new stake in Senseonics during the 4th quarter worth approximately $148,000. Finally, Geode Capital Management LLC lifted its holdings in Senseonics by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company's stock worth $3,354,000 after purchasing an additional 566,704 shares during the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.